Weight loss

Scientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less Nausea

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.

By Ed Cara Published March 16, 2025

ScienceHealth

Does Ozempic Really Cause Thyroid Cancer? What the Science Actually Says

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

By Ed Cara Published March 8, 2025

ScienceHealth

Ozempic Not Working for You? A Stomach Balloon Is the Latest Hope for Weight Loss

MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.

By Margherita Bassi Published December 8, 2024

ScienceHealth

Losing Weight With Ozempic Might Also Lighten Your Bar Tab, Study Finds

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be adapted into treatments for substance use disorders.

By Ed Cara Published November 26, 2024

ScienceHealth

A Staggering Number of U.S. Adults Are Eligible for Ozempic, Study Finds

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

By Ed Cara Published November 19, 2024

ScienceHealth

Landmark Study Finds Life-Altering Benefits for Teens a Decade After Weight Loss Surgery

Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a decade earlier.

By Ed Cara Published October 30, 2024

ScienceHealth

Ozempic Could Be Lifesaving for Thousands of Americans a Year, Study Finds

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

By Ed Cara Published October 18, 2024

ScienceHealth

Good and Bad News on the Obesity Front in the U.S.

The rate of adult obesity has finally stopped climbing in recent years, new CDC data shows.

By Ed Cara Published September 24, 2024

ScienceHealth

How Ozempic Works—and What’s Still a Mystery

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect our body? And what's left to learn?

By Ed Cara Published September 21, 2024

ScienceHealth

Experimental Weight Loss Drug Beat Ozempic and Wegovy in Early Trial

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.

By Ed Cara Published September 12, 2024

ScienceHealth

‘Gelzempic’ Could Make Popular Weight Loss Drugs Easier to Take

Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.

By Ed Cara Published September 7, 2024

ScienceHealth

Does Ozempic Burn Fat or Just Reduce Appetite? A New Study Offers a Clue

GLP-1 drugs are effective weight loss tools, but exactly how they work is still mysterious.

By Ed Cara Published August 22, 2024

Boxes of diabetes medication Mounjaro, containing active ingredient tirzepatide.

ScienceHealth

A Man’s Rapid Weight Loss From Obesity Drug Led to Heart Problems

A case report highlights the danger of mixing certain medications with the newest generation of weight-loss drugs.

By Ed Cara Published August 6, 2024

A photo of semaglutide tablets and injection pens.

Science

Messing With Brain Proteins Made Ozempic-Like Drugs More Effective, Less Nauseating

Semaglutide doesn't work for everyone and can have side effects, but a study in mice may point to a solution.

By Adam Kovac Published July 17, 2024

ScienceHealth

Ozempic and Other GLP-1 Drugs May Cut Cancer Risk

New research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.

By Ed Cara Published July 5, 2024

ScienceHealth

Ozempic and Wegovy Linked to Rare Blindness Risk, Study Finds

New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.

By Ed Cara Published July 3, 2024

ScienceHealth

Next Gen Weight Loss Drugs Are Coming for Ozempic’s Throne

Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.

By Ed Cara Published June 25, 2024

ScienceHealth

Hey Teens, No Obesity Meds for You, Experts Say

Experts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe.

By Ed Cara Published June 18, 2024

ScienceHealth

The Truth About Ozempic and Muscle Loss

Critics claim that drugs like semaglutide and other GLP-1s can dangerously sap away our muscle mass, but what does the current science actually tell us?

By Ed Cara Published June 14, 2024